Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Acalabrutinib
NCCN Guidelines for Patients for CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
CLL Society
Cancer.gov